secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001641172-25-014877
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ernexa Therapeutics effects 1-for-15 reverse stock split effective June 12, 2025
--------------------------------------------------------------------------------

- Certificate of amendment filed with Delaware Secretary of State on June 10, 2025.
- Reverse stock split ratio is 1-for-15.
- Effective date of reverse stock split is June 12, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000164117225014877/0001641172-25-014877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000164117225014877/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer